CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 490,634	$ 239,602
Restricted Cash	17,460
Short-term investments	973,381	597,914
Accounts receivable	23,485	29,428
Unbilled receivable	23,862
Inventories	7,498	10,930
Prepaid expenses and other current assets	49,382	35,623
Total current assets	1,585,702	913,497
Property and equipment, net	76,990	62,568
Land use right, net	12,863	12,465
Intangible assets, net	7,062	7,250
Goodwill	109	109
Deferred tax assets	11,991	7,675
Other non-current assets	14,210	42,915
Total non-current assets	123,225	132,982
Total assets	1,708,927	1,046,479
Current liabilities:
Accounts payable	52,719	69,779
Accrued expenses and other payables	55,712	49,598
Deferred revenue, current portion	14,011	12,233
Tax payable	9,889	9,156
Current portion of long-term bank loan	9,565	9,222
Total current liabilities	141,896	149,988
Non-current liabilities:
Long-term bank loan	9,565	9,222
Shareholder loan	154,551	146,271
Deferred revenue, non-current portion	21,291	24,808
Other long-term liabilities	22,902	31,959
Total non-current liabilities	208,309	212,260
Total liabilities	350,205	362,248
Commitments and contingencies
Equity:
Ordinary shares (par value of US$0.0001 per share; 9,500,000,000 shares authorized; 698,942,730 shares issued and outstanding as of March 31, 2018 (December 31, 2017: 592,072,330 shares))	70	59
Additional paid-in capital	1,782,033	1,000,747
Accumulated other comprehensive income /(loss)	320	(480)
Accumulated deficit	(438,042)	(330,517)
Total BeiGene, Ltd. shareholders' equity	1,344,381	669,809
Noncontrolling interest	14,341	14,422
Total equity	1,358,722	684,231
Total liabilities and equity	$ 1,708,927	$ 1,046,479